Alaunos Therapeutics, Inc. (TCRT) Operating margin 2016–2025
Alaunos Therapeutics, Inc. (TCRT) operating margin by fiscal year — reported operating income divided by reported revenue.
-84500.0%FY2025 · since FY2016: -2409.4% → -84500.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -84500.0% | -36380.0 pp |
| FY2024 | -48120.0% | +637220.0 pp |
| FY2023 | -685340.0% | -684138.6 pp |
| FY2022 | -1201.4% | +18283.3 pp |
| FY2021 | -19484.7% | — |
| FY2018 | -36921.9% | -36084.7 pp |
| FY2017 | -837.3% | +1572.1 pp |
| FY2016 | -2409.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice